Trials / Unknown
UnknownNCT02974751
Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 178 (actual)
- Sponsor
- PROCEPT BioRobotics · Industry
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of the AQUABEAM System for the treatment of Lower Urinary Tract Symptoms (LUTS) resulting from Benign Prostatic Hyperplasia (BPH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Aquablation | Aquablation is a minimally invasive transurethral surgical procedure using the AQUABEAM system, a personalized image-guided waterject resection system that utilizes a high-velocity saline stream to resect and remove prostate tissue. |
Timeline
- Start date
- 2017-09-05
- Primary completion
- 2019-05-24
- Completion
- 2020-02-29
- First posted
- 2016-11-28
- Last updated
- 2019-10-22
Locations
5 sites across 5 countries: Australia, Germany, Lebanon, New Zealand, United Kingdom
Source: ClinicalTrials.gov record NCT02974751. Inclusion in this directory is not an endorsement.